Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

American Journal of Psychiatry

Volumn 157, Issue 7, 2000, Pages 1134-1140

  Jacobsen, Leslie K ^a   Staley, Julie K ^b   Malison, Robert T ^b   Zoghbi, Sami S ^b   Seibyl, John P ^b   Kosten, Thomas R ^b   Innis, Robert B ^b  

^a Psychiatry 116A   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN TRANSPORTER;

AGING; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG WITHDRAWAL; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RELAPSE; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGE FACTORS; BRAIN; BRAIN STEM; CARRIER PROTEINS; COCAINE; COCAINE-RELATED DISORDERS; DIENCEPHALON; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RECURRENCE; RISK FACTORS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0033934863     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.7.1134     Document Type: Article

References (59)

1. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnosis in chronic cocaine abusers. Arch Gen Psychiatry 1986; 43:107-113
2. Ritz MC, Cone EJ, Kuhar MJ: Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure activity study. Life Sci 1990; 46:635-645
3. Koob GF, Bloom FE: Cellular and molecular basis of drug dependence. Science 1988; 242:715-723
4. Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985; 9:469-477
5. Mendelson JH, Mello NK: Management of cocaine abuse and dependence. N Engl J Med 1996; 334:965-972
6. Baumann MH, Rothman RB: Serotonergic dysfunction during cocaine withdrawal: implications for cocaine-induced depression, in Neurochemistry of Drug Abuse. New York, CRC Press, 1998, pp 463-484
7. Parsons LH, Koob GF, Weiss F: Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 1995; 274: 1182-1191
8. Walsh SL, Cunningham KA: Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berl) 1997; 130:41-58
9. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, UhL GR: Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad SCi USA 1998; 95:7699-7704
10. Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR, Heninger GR, Price LH: Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl) 1995; 119:179-185
11. Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS: Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry 1995; 152:778-783
12. Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE: Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 1994; 14:396-407
13. Grabowski J, Rhoades H, Elk R, Schmilz J, Davis C, Creson D, Kirby K: Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol 1995; 15:163-174
14. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH: Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155:207-213
15. Bergstrom KA, Jolkkonen J, Kuikka JT, Akerman KK, Viinamaki H, Airaksinen O, Lansimies E, Tiihonen J: Fentanyl decreases beta-CIT binding to the dopamine transporter. Synapse 1998; 29:413-415
16. Basile MJ, Izenwasser S, Staley JK, Mash DC: Serotonin transporter regulation in human cocaine abusers. Abstracts of the Society for Neuroscience 1999; 25:562
17. 123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13: 295-309
18. 3H]paroxetine. Neuroscience 1988; 27:473-496
19. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1997
20. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N: The Schedule for Affective Disorders and Schizophrenia for School Aged Children: Present and Lifetime Version. Pittsburgh, University of Pittsburgh, Western Psychiatric Institute and Clinic, 1996
21. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
22. Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-890
23. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14:982-994
24. Rajeevan N, Zubal IG, Ramsby SQ, Zoghbi SS, Seibyl J. Innis RB, Zoghbi S: Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. J Nucl Med 1998; 39:1719-1726
25. Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT: Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 1989; 13:20-26
26. Parent A: Carpenter's Human Neuroanatomy Baltimore, Williams & Wilkins, 1996
27. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, John Wiley & Sons, 1986
28. 2I. Neuroimage 1999; 9:108-116
29. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 1989; 486:261-268
30. Dahlstrom A, Fuxe K: Evidence for the existence of monoamine-containing neurons in the central nervous system, I: demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand Suppl 1964; 232:1-55
31. 123I]β-CIT SPECT. Am J Psychiatry 1998; 155:832-834
32. Staley JK, Hearn L, Ruttenber J, Wetli CV, Mash DC: High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 1994; 271:1678-1685
33. Hurd YL, Herkenham M: Molecular alterations in the neostriatum of human cocaine addicts. Synapse 1993; 13:357-369
34. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ: Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 1996; 40:428-439
35. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Gatley SJ, MacGregor RR, Wolf AP: Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 1996; 14:159-168
36. Little KY, McLaughlin DP, Zhang L, McFinton PR, Dalack GW, Cook EH, Cassin BJ, Watson SJ: Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Arch Gen Psychiatry 1998; 55:793-799
37. Amara SG, Kuhar MJ: Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993; 16:73-93
38. Baumann MH, Raley TJ, Partilla JS, Rothman RB: Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissectior mapping study. Synapse 1993; 14:40-50
39. 123I]β-CIT SPECT imaging in primate brain (abstract). J Nucl Med 1998; 39:42P
40. Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D, Zajicek K, Suomi SJ, Lesch K-P, Weinberger DR, Linnoila M: In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 1998; 155:1023-1026
41. 3H]imipramine binding sites in rat cerebral cortex. Eur J Pharmacol 1985; 110:393-394
42. Delgado PM, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS: Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999; 46:212-220
43. Berman RM, Narasimhan M, Miller HL, Anand A, Cappiello A, Oren DA, Heninger GR, Charney DS: Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Psychiatry 1999; 56:395-403
44. Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J: Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) 1999; 144:282-285
45. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 1998; 44:1090-1098
46. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M: Reduced central serotonin transporters in alcoholism. Am J Psychiatry 1998; 155:1544-1549
47. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD: Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991; 148:1712-1716
48. Higley JD, Linnoila M: Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior: a nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann NY Acad Sci 1997; 836:39-56
49. Laine TPJ, Ahonen A, Torniainen P, Heikkila J, Pyhtinen J, Rasanen P, Niemela O, Hillbom M: Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry 1999; 4:189-191
50. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB: Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med 1995; 36:1175-1181
51. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Hitzemann R, Smith G, Fields SD, Gur R: Dopamine transporters decrease with age. J Nucl Med 1996; 37:554-559
52. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 1993; 620:163-166
53. Stockmeier CA, Shapiro LA, Haycock JW, Thompson PA, Lowy MT: Quantitative subregional distribution of serotonin-1A receptors and serotonin transporters in the human dorsal raphe. Brain Res 1996; 727:1-12
54. 3H]imipramine binding in aged human brain. J Neurochem 1985; 45:1382-1389
55. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Reider N, Angelberger P, Brucke T: Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 2000; 41:36-44
56. van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB: Age related decline in central serotonin transporter availability with [123I]β-CIT SPECT. Neurobiol Aging (in press)
57. 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine. Life Sci 1993; 52:1767-1775
58. Yamaguchi T, Yamagata A: Serotonergic ligand binding in aging brain of experimental animals. Biochem Res 1991; 16:469-473
59. Roose SP, Glassman AH, Attia E, Woodring S: Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735-1739